Suppr超能文献

根据巨细胞病毒抗原状态治疗的溃疡性结肠炎患者的长期随访

Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.

作者信息

Inokuchi Toshihiro, Kato Jun, Hiraoka Sakiko, Suzuki Hideyuki, Nakarai Asuka, Hirakawa Tomoko, Akita Mitsuhiro, Takahashi Sakuma, Harada Keita, Okada Hiroyuki, Yamamoto Kazuhide

机构信息

Toshihiro Inokuchi, Sakiko Hiraoka, Hideyuki Suzuki, Asuka Nakarai, Tomoko Hirakawa, Mitsuhiro Akita, Sakuma Takahashi, Keita Harada, Hiroyuki Okada, Kazuhide Yamamoto, Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

出版信息

World J Gastroenterol. 2014 Jan 14;20(2):509-17. doi: 10.3748/wjg.v20.i2.509.

Abstract

AIM

To clarify the impact of cytomegalovirus (CMV) activation and antiviral therapy based on CMV antigen status on the long-term clinical course of ulcerative colitis (UC) patients.

METHODS

UC patients with flare-up were divided into CMV-positive and -negative groups according to the CMV antigenemia assay. The main treatment strategy provided for the patients in the CMV-positive group comprised a dose reduction of corticosteroids and administration of ganciclovir.

RESULTS

The median number of days to initial remission was significantly greater for the patients in the CMV-positive group (21 d vs 16 d, P = 0.009). However, the relapse rate after remission and colectomy rate during more than 30 mo of observation did not differ between the two groups. Multivariate analysis revealed that administration of ganciclovir was the only independent factor for avoiding colectomy in patients of the CMV-positive group.

CONCLUSION

CMV antigen status did not significantly affect the long-term prognosis in UC patients under treatment with appropriate antiviral therapy.

摘要

目的

阐明巨细胞病毒(CMV)激活及基于CMV抗原状态的抗病毒治疗对溃疡性结肠炎(UC)患者长期临床病程的影响。

方法

将病情发作的UC患者根据CMV抗原血症检测分为CMV阳性组和阴性组。为CMV阳性组患者提供的主要治疗策略包括减少皮质类固醇剂量及给予更昔洛韦。

结果

CMV阳性组患者至初始缓解的中位天数显著更长(21天对16天,P = 0.009)。然而,两组在缓解后的复发率及超过30个月观察期内的结肠切除术率并无差异。多变量分析显示,给予更昔洛韦是CMV阳性组患者避免行结肠切除术的唯一独立因素。

结论

在接受适当抗病毒治疗的UC患者中,CMV抗原状态对长期预后无显著影响。

相似文献

1
Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.
World J Gastroenterol. 2014 Jan 14;20(2):509-17. doi: 10.3748/wjg.v20.i2.509.
3
Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
World J Gastroenterol. 2016 Feb 14;22(6):2030-45. doi: 10.3748/wjg.v22.i6.2030.
4
Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment.
Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1146-51. doi: 10.1097/MEG.0000000000000175.
8
Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
Am J Gastroenterol. 2011 Nov;106(11):2001-8. doi: 10.1038/ajg.2011.202. Epub 2011 Jul 26.

引用本文的文献

1
Diagnostic performance of noninvasive tests for cytomegalovirus ileocolitis: a systematic review and meta-analysis.
Intest Res. 2025 Apr;23(2):213-224. doi: 10.5217/ir.2024.00136. Epub 2025 Jan 14.
2
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment.
J Clin Med. 2023 Dec 26;13(1):130. doi: 10.3390/jcm13010130.
3
Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis.
Diagnostics (Basel). 2021 Oct 21;11(11):1952. doi: 10.3390/diagnostics11111952.
7
Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis.
J Clin Diagn Res. 2017 Mar;11(3):EC07-EC11. doi: 10.7860/JCDR/2017/22816.9332. Epub 2017 Mar 1.
9
Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
World J Gastroenterol. 2016 Feb 14;22(6):2030-45. doi: 10.3748/wjg.v22.i6.2030.
10
Cytomegalovirus in inflammatory bowel disease: A systematic review.
World J Gastroenterol. 2016 Jan 21;22(3):1321-30. doi: 10.3748/wjg.v22.i3.1321.

本文引用的文献

1
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.
J Crohns Colitis. 2012 Dec;6(10):965-90. doi: 10.1016/j.crohns.2012.09.003. Epub 2012 Oct 3.
2
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
J Crohns Colitis. 2012 Dec;6(10):991-1030. doi: 10.1016/j.crohns.2012.09.002. Epub 2012 Oct 3.
4
Management of cytomegalovirus infection in inflammatory bowel diseases.
Dig Liver Dis. 2012 Jul;44(7):541-8. doi: 10.1016/j.dld.2012.03.018. Epub 2012 Apr 25.
5
Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.
Am J Gastroenterol. 2011 Nov;106(11):2001-8. doi: 10.1038/ajg.2011.202. Epub 2011 Jul 26.
6
Cytomegalovirus Reactivation in Ulcerative Colitis Patients.
Ulcers. 2011 Jan 1;2011. doi: 10.1155/2011/282507.
7
Guidelines for the management of inflammatory bowel disease in adults.
Gut. 2011 May;60(5):571-607. doi: 10.1136/gut.2010.224154.
8
Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients.
World J Gastroenterol. 2011 Mar 7;17(9):1185-91. doi: 10.3748/wjg.v17.i9.1185.
9
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
J Crohns Colitis. 2009 Jun;3(2):47-91. doi: 10.1016/j.crohns.2009.02.010. Epub 2009 Apr 26.
10
Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?
Inflamm Bowel Dis. 2010 Sep;16(9):1620-7. doi: 10.1002/ibd.21275.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验